Glaxo Wellcome Manufacturing Pte. Ltd
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- Singapore
- Registered address
- 1, Pioneer Sector 1, Jurong, 628413, Singapore (SGP)
- Operations here
- analysisapi manufactureparticle size reduction
- FDA identifiers
- FEI 3002807079 · DUNS 595295577
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2023-10-13
- NAIDrug Quality Assurance2022-09-02
- VAIDrug Quality Assurance2018-06-01
- NAIDrug Quality Assurance2014-01-16
- NAIDrug Quality Assurance2012-11-16
- NAIDrug Quality Assurance2009-03-13
Drugs this plant is listed as making
2 distinct drugs across 3 products name this site in their FDA label.
- cabotegravir and rilpivirineViiV Healthcare Company
- Sumatriptan Succinate and Naproxen SodiumCurrax Pharmaceuticals LLC
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.